Back to Search Start Over

Anti-proliferative and apoptotic activities of constituents of chloroform extract ofJuglans regialeaves

Authors :
M. Salimi
M. H. Ardestaniyan
H. Mostafapour Kandelous
S. Saeidnia
A. R. Gohari
A. Amanzadeh
H. Sanati
Z. Sepahdar
S. Ghorbani
Source :
Cell Proliferation. 47:172-179
Publication Year :
2014
Publisher :
Wiley, 2014.

Abstract

Objectives To evaluate anti-proliferative as well as apoptotic activities of compounds identified in chloroform extract of Juglans regia leaves, on human breast and oral cancer cell lines (MCF-7 and BHY). Materials and methods Column chromatography, MTT assay, flowcytometry and western blotting have all been used in the study. Results Bioassay-guided fractionation of chloroform extract of J. regia afforded isolation of 5-hydroxy-3,7,4′-trimethoxyflavone [1], lupeol [2], daucosterol [3], 4-hydroxy-α-tetralone [4], β-sitosterol [5], 5,7- dihydroxy-3,4′-dimethoxyflavone [6] and regiolone [7]. Structures of the compounds were established on the basis of spectroscopic analyses [Nuclear magnetic resonance (NMR) and mass]. All compounds inhibited proliferation of MCF-7 (human breast adenocarcinoma) and BHY (human oral squamous carcinoma) cells in a concentration-dependent manner. Compounds 6 and 7 had potent cytotoxic effects on both MCF-7 and BHY cells (IC50 21–51 μm), yet were not toxic to normal cells. MCF-7 growth inhibition was attributed to apoptosis; population of apoptotic cells increased from 1.12% in controls to 5.64 and 8.1% after 48-h treatment with compounds 6 and 7, indicating their potential at inducing early and late apoptosis. The caspase cascade was not activated, as indicated by only insignificant cleavage of caspase-3. Conclusions Our results suggest that compounds 6 and 7 can induce apoptosis in MCF-7 cells through the caspase-3 independent pathway.

Details

ISSN :
09607722
Volume :
47
Database :
OpenAIRE
Journal :
Cell Proliferation
Accession number :
edsair.doi.dedup.....74d97ec1f23226f77ba41159f885677f
Full Text :
https://doi.org/10.1111/cpr.12090